IL247501B - Process for producing a stable low concentration, injectable solution of noradrenaline - Google Patents

Process for producing a stable low concentration, injectable solution of noradrenaline

Info

Publication number
IL247501B
IL247501B IL247501A IL24750116A IL247501B IL 247501 B IL247501 B IL 247501B IL 247501 A IL247501 A IL 247501A IL 24750116 A IL24750116 A IL 24750116A IL 247501 B IL247501 B IL 247501B
Authority
IL
Israel
Prior art keywords
norepinephrine
preparing
stable
solution containing
low concentration
Prior art date
Application number
IL247501A
Other languages
English (en)
Hebrew (he)
Other versions
IL247501A0 (en
Inventor
Donati Elisabetta
Caronzolo Nicola
Mitidieri Augusto
Original Assignee
Sintetica S A
Donati Elisabetta
Caronzolo Nicola
Mitidieri Augusto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50693780&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL247501(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sintetica S A, Donati Elisabetta, Caronzolo Nicola, Mitidieri Augusto filed Critical Sintetica S A
Publication of IL247501A0 publication Critical patent/IL247501A0/en
Publication of IL247501B publication Critical patent/IL247501B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IL247501A 2014-02-27 2016-08-25 Process for producing a stable low concentration, injectable solution of noradrenaline IL247501B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20140306 2014-02-27
PCT/EP2015/054021 WO2015128418A1 (en) 2014-02-27 2015-02-26 Process for producing a stable low concentration, injectable solution of noradrenaline

Publications (2)

Publication Number Publication Date
IL247501A0 IL247501A0 (en) 2016-11-30
IL247501B true IL247501B (en) 2020-05-31

Family

ID=50693780

Family Applications (1)

Application Number Title Priority Date Filing Date
IL247501A IL247501B (en) 2014-02-27 2016-08-25 Process for producing a stable low concentration, injectable solution of noradrenaline

Country Status (43)

Country Link
US (4) USRE49422E1 (enExample)
EP (1) EP3110399B1 (enExample)
JP (1) JP6635927B2 (enExample)
KR (1) KR102306706B1 (enExample)
CN (1) CN106061467B (enExample)
AP (1) AP2016009467A0 (enExample)
AR (1) AR101148A1 (enExample)
AU (1) AU2015222150B2 (enExample)
BR (1) BR112016019804B1 (enExample)
CA (1) CA2940347C (enExample)
CL (1) CL2016002073A1 (enExample)
CR (1) CR20160420A (enExample)
CY (1) CY1120125T1 (enExample)
DK (1) DK3110399T3 (enExample)
DO (1) DOP2016000210A (enExample)
EA (1) EA031444B1 (enExample)
EC (1) ECSP16065957A (enExample)
ES (1) ES2663817T3 (enExample)
GE (1) GEP20186829B (enExample)
HR (1) HRP20180541T1 (enExample)
HU (1) HUE038738T2 (enExample)
IL (1) IL247501B (enExample)
JO (1) JO3552B1 (enExample)
LT (1) LT3110399T (enExample)
MA (1) MA39200A1 (enExample)
MD (1) MD4628C1 (enExample)
ME (1) ME03004B (enExample)
MX (1) MX367148B (enExample)
MY (1) MY179942A (enExample)
NI (1) NI201600118A (enExample)
PE (1) PE20161375A1 (enExample)
PH (1) PH12016501703B1 (enExample)
PL (1) PL3110399T3 (enExample)
PT (1) PT3110399T (enExample)
RS (1) RS57044B1 (enExample)
SG (1) SG11201607094WA (enExample)
SI (1) SI3110399T1 (enExample)
SM (1) SMT201800239T1 (enExample)
SV (1) SV2016005265A (enExample)
TW (1) TWI673065B (enExample)
UA (1) UA118043C2 (enExample)
UY (1) UY35988A (enExample)
WO (1) WO2015128418A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
PL2990031T3 (pl) 2014-08-28 2020-05-18 Sun Pharmaceutical Industries Ltd Pozajelitowa postać norepinefryny
CA3051467C (en) 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor
US20250177328A1 (en) 2017-01-30 2025-06-05 Nevakar Injectables Inc. Norepinephrine compositions and methods therefor
CN109394683A (zh) * 2018-12-07 2019-03-01 远大医药(中国)有限公司 一种重酒石酸去甲肾上腺素注射液的制备方法
US10888534B2 (en) * 2019-04-26 2021-01-12 InfoRLife SA Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
CA3174640A1 (en) * 2020-03-06 2021-09-10 Baxter International Inc. Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation
PL4051251T3 (pl) * 2020-10-21 2024-04-08 Sintetica S.A. Stabilne, wolne od antyoksydantów roztwory noradrenaliny do wstrzykiwania
US20220117843A1 (en) * 2020-10-21 2022-04-21 Sintetica S.A. Ready to use, noradrenaline drip bags, having low subvisible particle counts
US11331266B1 (en) * 2020-10-29 2022-05-17 Medefil, Inc. Antioxidant free, norepinephrine bitartrate injection in amber glass vials
US20220233473A1 (en) * 2021-01-28 2022-07-28 Cumberland Pharmaceuticals Inc. Injectable solution of norepinephrine
AR124867A1 (es) 2021-02-15 2023-05-10 Sintetica S A Un medicamento en una bolsa de goteo intravenoso plegable lista para usar herméticamente sellada, método para hacer dicho medicamento y medicamento elaborado mediante dicho método
CN116327697A (zh) * 2023-04-17 2023-06-27 福安药业集团庆余堂制药有限公司 一种重酒石酸去甲肾上腺素注射液及其制剂工艺

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
FR2832063B1 (fr) * 2001-11-15 2004-08-27 Aguettant Lab Procede de production de solutions stables de substances phenoliques et les solutions en resultant
BR0311965A (pt) 2002-06-20 2005-03-29 Novalar Pharmaceutical Inc Formulações estabilizadas de antagonistas de receptores alfa adrenérgicos e os seus usos
US20040005401A1 (en) 2002-07-05 2004-01-08 Robert Becker Method for applying a washcoat to suppport bodies
US7078876B2 (en) 2003-07-07 2006-07-18 Pentadyne Power Corporation Feedforward controller for synchronous reluctance machines
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
US7465489B2 (en) 2005-11-15 2008-12-16 Poly-Med, Inc. Inorganic-organic melted-extruded hybrid filaments and medical applications thereof
FR2894154B1 (fr) 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.
EP2096433A1 (de) 2008-02-26 2009-09-02 Siemens Aktiengesellschaft Vorrichtung zur zerstörungsfreien Materialprüfung eines Prüfgegenstands mit Ultraschallwellen
US8419689B2 (en) 2008-09-30 2013-04-16 Covidien Lp Enclosing package for medical port and cover
CN102802668A (zh) * 2009-06-04 2012-11-28 Alk股份公司 包含至少一种肾上腺素能化合物的稳定化组合物
US8628805B2 (en) 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
FR2963237B1 (fr) 2010-07-28 2013-05-17 Aguettant Lab Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain
CN102525895B (zh) 2012-01-04 2013-11-06 上海禾丰制药有限公司 重酒石酸去甲肾上腺素注射液及其制剂工艺
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
US20160005871A1 (en) 2014-07-04 2016-01-07 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device
CA3051467C (en) 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor

Also Published As

Publication number Publication date
US20170049720A1 (en) 2017-02-23
PL3110399T3 (pl) 2018-07-31
KR102306706B1 (ko) 2021-09-30
DOP2016000210A (es) 2016-11-30
AR101148A1 (es) 2016-11-30
USRE49443E1 (en) 2023-03-07
TWI673065B (zh) 2019-10-01
ECSP16065957A (es) 2017-01-31
MD4628B1 (ro) 2019-05-31
EP3110399A1 (en) 2017-01-04
MA39200A1 (fr) 2017-06-30
HUE038738T2 (hu) 2018-11-28
CL2016002073A1 (es) 2017-02-10
EA201691734A1 (ru) 2016-12-30
EA031444B1 (ru) 2019-01-31
USRE49555E1 (en) 2023-06-20
LT3110399T (lt) 2018-04-25
GEP20186829B (en) 2018-02-26
SMT201800239T1 (it) 2018-07-17
MY179942A (en) 2020-11-19
PH12016501703B1 (en) 2019-08-23
CN106061467B (zh) 2021-02-05
BR112016019804A2 (enExample) 2017-08-15
AU2015222150A1 (en) 2016-10-13
CA2940347C (en) 2021-04-27
ME03004B (me) 2018-10-20
MD4628C1 (ro) 2019-12-31
JP2017506632A (ja) 2017-03-09
AP2016009467A0 (en) 2016-09-30
CN106061467A (zh) 2016-10-26
CA2940347A1 (en) 2015-09-03
WO2015128418A1 (en) 2015-09-03
SV2016005265A (es) 2017-01-18
US10251848B2 (en) 2019-04-09
MX2016011148A (es) 2016-12-09
PH12016501703A1 (en) 2016-12-19
JO3552B1 (ar) 2020-07-05
MX367148B (es) 2019-08-07
KR20160122264A (ko) 2016-10-21
BR112016019804B1 (pt) 2022-03-03
EP3110399B1 (en) 2018-01-10
ES2663817T3 (es) 2018-04-17
SG11201607094WA (en) 2016-09-29
JP6635927B2 (ja) 2020-01-29
SI3110399T1 (en) 2018-05-31
AU2015222150B2 (en) 2019-12-05
HRP20180541T1 (hr) 2018-05-04
CR20160420A (es) 2016-12-14
RS57044B1 (sr) 2018-05-31
DK3110399T3 (en) 2018-04-09
MD20160103A2 (ro) 2017-01-31
UY35988A (es) 2015-09-30
TW201620499A (zh) 2016-06-16
UA118043C2 (uk) 2018-11-12
CY1120125T1 (el) 2018-12-12
PE20161375A1 (es) 2017-01-05
IL247501A0 (en) 2016-11-30
NI201600118A (es) 2016-10-03
USRE49422E1 (en) 2023-02-21
PT3110399T (pt) 2018-04-19

Similar Documents

Publication Publication Date Title
IL247501B (en) Process for producing a stable low concentration, injectable solution of noradrenaline
LT3190113T (lt) Pirolopirimidino junginiai, naudotini kaip tlr7 agonistai
IL250923A0 (en) Novel compounds as rearranged during transfection (ret) inhibitors
HUE052475T2 (hu) Eljárás diaril-tiohidantoin vegyület elõállítására
DK3165507T3 (da) Fremgangsmåde til fremstilling af porøs grafen
EP3209720C0 (en) Continuous solution polymerization process
DK3233843T3 (da) Isoxazol-hydraxamsyreforbindelser som LPXC-hæmmere
IL246447A0 (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
BR112016026212A2 (pt) Processo para preparar cianidrina contendo fósforo
EP3212524C0 (en) METHOD FOR MANUFACTURING A CONTAINER PRECURSOR
HUE042349T2 (hu) Eljárás diariltiohidantoin vegyület elõállítására
HUE041438T2 (hu) Eljárás optikailag aktív izoxazolin vegyületek elõállítására
DK3324937T3 (da) Brugsfærdig bortezomib-opløsning
BR112016027556A2 (pt) métodos de preparação de um composto
EP3286306A4 (en) Novel process
ME03012B (me) Nova upotreba n,n-bis-2-merkaptoetil izoftalamida
BR112017000697A2 (pt) “processo para a produção de compostos de biaril”
PL3324935T3 (pl) Roztwór wodny zawierający stilbenoid
DK3341343T3 (da) Fremgangsmåde til fremstilling af et legeme omfattende porøs alphasiliciumkarbid
HUE059571T2 (hu) Akrilsav származékot tartalmazó készítmény, valamint eljárás akrilsav származék stabilizálására
LT3110812T (lt) Anti-amiloidų junginiai, turintys benzofurazano
TH1601000381A (th) สารประกอบอินโดไลซีนแบบใหม่, กระบวนการในการเตรียมสารประกอบดังกล่าว และองค์ประกอบทางเภสัชกรรมที่ประกอบด้วยสารประกอบดังกล่าว
TH1501007313A (th) เซลล์ของสัตว์ปีกเพื่อการผลิตไวรัสที่ปรับปรุงขึ้น
TH1501007345A (th) กระบวนการเพื่อการเตรียมโทโคฟีรอลเข้มข้น
IL244646A0 (en) Process for preparing 5-fluoro-1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carbaldehyde

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed